Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice
In: Beneficial MicrobesSearch for other papers by L.K. Stenman in
Current site
Google Scholar
Search for other papers by A. Waget in
Current site
Google Scholar
Search for other papers by C. Garret in
Current site
Google Scholar
Search for other papers by P. Klopp in
Current site
Google Scholar
Search for other papers by R. Burcelin in
Current site
Google Scholar
Search for other papers by S. Lahtinen in
Current site
Google Scholar
Alterations of the gut microbiota and mucosal barrier are linked with metabolic diseases. Our aim was to investigate the potential benefit of the potential probiotic Bifidobacterium animalis ssp. lactis 420 in reducing high-fat diet-induced body weight gain and diabetes in mice. In the obesity model, C57Bl/6J mice were fed a high-fat diet (60 energy %) for 12 weeks, and gavaged daily with B. lactis 420 (109 cfu) or vehicle. In the diabetes model, mice were fed a high-fat, ketogenic diet (72 energy % fat) for 4 weeks, with a 6-week subsequent treatment with B. lactis 420 (108-1010 cfu/day) or vehicle, after which they were analysed for body composition. We also analysed glucose tolerance, plasma lipopolysaccharide and target tissue inflammation using only one of the B. lactis 420 groups (109 cfu/day). Intestinal bacterial translocation and adhesion were analysed in a separate experiment using an Escherichia coli gavage. Body fat mass was increased in both obese (10.7±0.8 g (mean ± standard error of mean) vs. 1.86±0.21 g, P<0.001) and diabetic mice (3.01±0.4 g vs. 1.14±0.15 g, P<0.001) compared to healthy controls. Treatment with B. lactis 420 significantly decreased fat mass in obese (7.83 ± 0.67 g, P=0.007 compared to obese with vehicle) and diabetic mice (1.89 ± 0.16 g, P=0.02 for highest dose). This was reflected as reduced weight gain and improved glucose tolerance. Furthermore, B. lactis 420 decreased plasma lipopolysaccharide levels (P<0.001), liver inflammation (P=0.04), and E. coli adhesion in the distal gut (P<0.05). In conclusion, B. lactis 420 reduces fat mass and glucose intolerance in both obese and diabetic mice. Reduced intestinal mucosal adherence and plasma lipopolysaccharide suggest a mechanism related to reduced translocation of gut microbes.
-
Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermudez- Humaran, L.G., Smirnova, N., Berge, M., Sulpice, T., Lahtinen, S., Ouwehand, A., Langella, P., Rautonen, N., Sansonetti, P.J. and Burcelin, R., 2011. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Molecular Medicine 3: 559-572.
'Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment ' () 3 EMBO Molecular Medicine : 559 -572.
-
Andreasen, A.S., Larsen, N., Pedersen-Skovsgaard, T., Berg, R.M., Moller, K., Svendsen, K.D., Jakobsen, M. and Pedersen, B.K., 2010. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. British Journal of Nutrition 104: 1831-1838.
'Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects ' () 104 British Journal of Nutrition : 1831 -1838.
-
Asemi, Z., Samimi, M., Tabassi, Z., Naghibi Rad, M., Rahimi Foroushani, A., Khorammian, H. and Esmaillzadeh, A., 2013. Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial. European Journal of Clinical Nutrition 67: 71-74.
'Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial ' () 67 European Journal of Clinical Nutrition : 71 -74.
-
Backhed, F., Manchester, J.K., Semenkovich, C.F. and Gordon, J.I., 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the USA 104: 979-984.
'Mechanisms underlying the resistance to diet-induced obesity in germ-free mice ' () 104 Proceedings of the National Academy of Sciences of the USA : 979 -984.
-
Bermudez-Brito, M., Plaza-Diaz, J., Munoz-Quezada, S., Gomez-Llorente, C. and Gil, A., 2012. Probiotic mechanisms of action. Annals of Nutrition and Metabolism 61: 160-174.
'Probiotic mechanisms of action ' () 61 Annals of Nutrition and Metabolism : 160 -174.
-
Burcelin, R., Crivelli, V., Dacosta, A., Roy-Tirelli, A. and Thorens, B., 2002. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. American Journal of Physiology: Endocrinology and Metabolism 282: E834-E842.
'Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet ' () 282 American Journal of Physiology: Endocrinology and Metabolism : E834 -E842.
-
Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A.M., Fava, F., Tuohy, K.M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J.F., Gibson, G.R., Casteilla, L., Delzenne, N.M., Alessi, M.C. and Burcelin, R., 2007a. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772.
'Metabolic endotoxemia initiates obesity and insulin resistance ' () 56 Diabetes : 1761 -1772.
-
Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
'Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice ' () 57 Diabetes : 1470 -1481.
-
Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., Gibson, G.R. and Delzenne, N.M., 2007b. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383.
'Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia ' () 50 Diabetologia : 2374 -2383.
-
Cano, P.G., Santacruz, A., Trejo, F.M. and Sanz, Y., 2013. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. Obesity 21: 2310-2321.
'Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice ' () 21 Obesity : 2310 -2321.
-
Carvalho, B.M., Guadagnini, D., Tsukumo, D.M., Schenka, A.A., Latuf-Filho, P., Vassallo, J., Dias, J.C., Kubota, L.T., Carvalheira, J.B. and Saad, M.J., 2012. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 55: 2823-2834.
'Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice ' () 55 Diabetologia : 2823 -2834.
-
Chen, J.J., Wang, R., Li, X.F. and Wang, R.L., 2011. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Experimental Biology and Medicine 236: 823-831.
'Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression ' () 236 Experimental Biology and Medicine : 823 -831.
-
Collado, M.C., Meriluoto, J. and Salminen, S., 2007. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Letters in Applied Microbiology 45: 454-460.
'Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus ' () 45 Letters in Applied Microbiology : 454 -460.
-
De la Serre, C.B., Ellis, C.L., Lee, J., Hartman, A.L., Rutledge, J.C. and Raybould, H.E., 2010. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. American Journal of Physiology: Gastrointestinal and Liver Physiology 299: G440-G448.
'Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation ' () 299 American Journal of Physiology: Gastrointestinal and Liver Physiology : G440 -G448.
-
Everard, A., Geurts, L., Van Roye, M., Delzenne, N.M. and Cani, P.D., 2012. Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice. PloS One 7: e33858.
'Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice ' () 7 PloS One : e33858.
-
Ghoshal, S., Witta, J., Zhong, J., de Villiers, W. and Eckhardt, E., 2009. Chylomicrons promote intestinal absorption of lipopolysaccharides. Journal of Lipid Research 50: 90-97.
'Chylomicrons promote intestinal absorption of lipopolysaccharides ' () 50 Journal of Lipid Research : 90 -97.
-
Hotamisligil, G.S., 2006. Inflammation and metabolic disorders. Nature 444: 860-867.
'Inflammation and metabolic disorders ' () 444 Nature : 860 -867.
-
Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., Okano, M., Kagoshima, M. and Tsuchida, T., 2010. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition 64: 636-643.
'Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial ' () 64 European Journal of Clinical Nutrition : 636 -643.
-
Kadooka, Y., Sato, M., Ogawa, A., Miyoshi, M., Uenishi, H., Ogawa, H., Ikuyama, K., Kagoshima, M. and Tsuchida, T., 2013. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition 110: 1696-1703.
'Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial ' () 110 British Journal of Nutrition : 1696 -1703.
-
Keita, A.V., Salim, S.Y., Jiang, T., Yang, P.C., Franzen, L., Soderkvist, P., Magnusson, K.E. and Soderholm, J.D., 2008. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease. Journal of Pathology 215: 135-144.
'Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease ' () 215 Journal of Pathology : 135 -144.
-
Kim, K.A., Gu, W., Lee, I.A., Joh, E.H. and Kim, D.H., 2012. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PloS One 7: e47713.
'High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway ' () 7 PloS One : e47713.
-
Kim, S.W., Park, K.Y., Kim, B., Kim, E. and Hyun, C.K., 2013. Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochemical and Biophysical Research Communications 431: 258-263.
'Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production ' () 431 Biochemical and Biophysical Research Communications : 258 -263.
-
Kondo, S., Xiao, J.Z., Satoh, T., Odamaki, T., Takahashi, S., Sugahara, H., Yaeshima, T., Iwatsuki, K., Kamei, A. and Abe, K., 2010. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Bioscience, Biotechnology, and Biochemistry 74: 1656-1661.
'Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity ' () 74 Bioscience, Biotechnology, and Biochemistry : 1656 -1661.
-
Luche, E., Cousin, B., Garidou, L., Serino, M., Waget, A., Barreau, C., Andre, M., Valet, P., Courtney, M., Casteilla, L. and Burcelin, R., 2013. Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism. Molecular Metabolism 2: 281-291.
'Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism ' () 2 Molecular Metabolism : 281 -291.
-
Muccioli, G.G., Naslain, D., Backhed, F., Reigstad, C.S., Lambert, D.M., Delzenne, N.M. and Cani, P.D., 2010. The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 6: 392.
'The endocannabinoid system links gut microbiota to adipogenesis ' () 6 Molecular Systems Biology : 392.
-
Park, D.Y., Ahn, Y.T., Park, S.H., Huh, C.S., Yoo, S.R., Yu, R., Sung, M.K., McGregor, R.A. and Choi, M.S., 2013. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PloS One 8: e59470.
'Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity ' () 8 PloS One : e59470.
-
Pussinen, P.J., Havulinna, A.S., Lehto, M., Sundvall, J. and Salomaa, V., 2011. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 34: 392-397.
'Endotoxemia is associated with an increased risk of incident diabetes ' () 34 Diabetes Care : 392 -397.
-
Putaala, H., Salusjarvi, T., Nordstrom, M., Saarinen, M., Ouwehand, A.C., Bech Hansen, E. and Rautonen, N., 2008. Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Research in Microbiology 159: 692-698.
'Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression ' () 159 Research in Microbiology : 692 -698.
-
Rabot, S., Membrez, M., Bruneau, A., Gerard, P., Harach, T., Moser, M., Raymond, F., Mansourian, R. and Chou, C.J., 2010. Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB Journal 24: 4948-4959.
'Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism ' () 24 FASEB Journal : 4948 -4959.
-
Sato, M., Uzu, K., Yoshida, T., Hamad, E.M., Kawakami, H., Matsuyama, H., Abd El-Gawad, I.A. and Imaizumi, K., 2008. Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. British Journal of Nutrition 99: 1013-1017.
'Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats ' () 99 British Journal of Nutrition : 1013 -1017.
-
Schertzer, J.D., Tamrakar, A.K., Magalhaes, J.G., Pereira, S., Bilan, P.J., Fullerton, M.D., Liu, Z., Steinberg, G.R., Giacca, A., Philpott, D.J. and Klip, A., 2011. NOD1 activators link innate immunity to insulin resistance. Diabetes 60: 2206-2215.
'NOD1 activators link innate immunity to insulin resistance ' () 60 Diabetes : 2206 -2215.
-
Serino, M., Luche, E., Gres, S., Baylac, A., Berge, M., Cenac, C., Waget, A., Klopp, P., Iacovoni, J., Klopp, C., Mariette, J., Bouchez, O., Lluch, J., Ouarne, F., Monsan, P., Valet, P., Roques, C., Amar, J., Bouloumie, A., Theodorou, V. and Burcelin, R., 2012. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61: 543-553.
'Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota ' () 61 Gut : 543 -553.
-
Stenman, L.K., Holma, R., Eggert, A. and Korpela, R., 2013. A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids. American Journal Physiology: Gastrointestinal and Liver Physiology 304: G227-G234.
'A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids ' () 304 American Journal Physiology: Gastrointestinal and Liver Physiology : G227 -G234.
-
Stenman, L.K., Holma, R. and Korpela, R., 2012. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World Journal of Gastroenterology 18: 923-929.
'High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids ' () 18 World Journal of Gastroenterology : 923 -929.
-
Yadav, H., Lee, J.H., Lloyd, J., Walter, P. and Rane, S.G., 2013. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry 288: 25088-25097.
'Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion ' () 288 Journal of Biological Chemistry : 25088 -25097.
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 364 | 359 | 38 |
| PDF Views & Downloads | 429 | 422 | 38 |
Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice
In: Beneficial MicrobesSearch for other papers by L.K. Stenman in
Current site
Google Scholar
PubMed
Search for other papers by A. Waget in
Current site
Google Scholar
PubMed
Search for other papers by C. Garret in
Current site
Google Scholar
PubMed
Search for other papers by P. Klopp in
Current site
Google Scholar
PubMed
Search for other papers by R. Burcelin in
Current site
Google Scholar
PubMed
Search for other papers by S. Lahtinen in
Current site
Google Scholar
PubMed
Alterations of the gut microbiota and mucosal barrier are linked with metabolic diseases. Our aim was to investigate the potential benefit of the potential probiotic Bifidobacterium animalis ssp. lactis 420 in reducing high-fat diet-induced body weight gain and diabetes in mice. In the obesity model, C57Bl/6J mice were fed a high-fat diet (60 energy %) for 12 weeks, and gavaged daily with B. lactis 420 (109 cfu) or vehicle. In the diabetes model, mice were fed a high-fat, ketogenic diet (72 energy % fat) for 4 weeks, with a 6-week subsequent treatment with B. lactis 420 (108-1010 cfu/day) or vehicle, after which they were analysed for body composition. We also analysed glucose tolerance, plasma lipopolysaccharide and target tissue inflammation using only one of the B. lactis 420 groups (109 cfu/day). Intestinal bacterial translocation and adhesion were analysed in a separate experiment using an Escherichia coli gavage. Body fat mass was increased in both obese (10.7±0.8 g (mean ± standard error of mean) vs. 1.86±0.21 g, P<0.001) and diabetic mice (3.01±0.4 g vs. 1.14±0.15 g, P<0.001) compared to healthy controls. Treatment with B. lactis 420 significantly decreased fat mass in obese (7.83 ± 0.67 g, P=0.007 compared to obese with vehicle) and diabetic mice (1.89 ± 0.16 g, P=0.02 for highest dose). This was reflected as reduced weight gain and improved glucose tolerance. Furthermore, B. lactis 420 decreased plasma lipopolysaccharide levels (P<0.001), liver inflammation (P=0.04), and E. coli adhesion in the distal gut (P<0.05). In conclusion, B. lactis 420 reduces fat mass and glucose intolerance in both obese and diabetic mice. Reduced intestinal mucosal adherence and plasma lipopolysaccharide suggest a mechanism related to reduced translocation of gut microbes.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 364 | 359 | 38 |
| PDF Views & Downloads | 429 | 422 | 38 |